{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:32:57Z","timestamp":1777462377749,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T00:00:00Z","timestamp":1398816000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2407-14-304","type":"journal-article","created":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T17:02:05Z","timestamp":1398877325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity"],"prefix":"10.1186","volume":"14","author":[{"given":"Lourdes","family":"Cortes-Dericks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurene","family":"Froment","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Boesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph Alexander","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golnaz","family":"Karoubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,30]]},"reference":[{"key":"4479_CR1","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1158\/1078-0432.CCR-08-1579","volume":"15","author":"F Vandermeers","year":"2009","unstructured":"Vandermeers F, Hubert P, Delvenne P, Mascaux C, Grigoriu B, Burny A, Scherpereel A, Willems L: Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma. Clin Cancer Res. 2009, 15: 2818-2828. 10.1158\/1078-0432.CCR-08-1579.","journal-title":"Clin Cancer Res"},{"key":"4479_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11864-008-0071-3","volume":"9","author":"HL Kindler","year":"2008","unstructured":"Kindler HL: Systemic treatments for mesothelioma: standard and novel. Curr Treat Options Oncol. 2008, 9: 171-179. 10.1007\/s11864-008-0071-3.","journal-title":"Curr Treat Options Oncol"},{"key":"4479_CR3","doi-asserted-by":"publisher","first-page":"9339","DOI":"10.1158\/0008-5472.CAN-06-3126","volume":"66","author":"MF Clarke","year":"2006","unstructured":"Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CHM, Jones DL, Visvader J, Weissman IL, Wahl GM: Cancer stem cells\u2013perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006, 66: 9339-9344. 10.1158\/0008-5472.CAN-06-3126.","journal-title":"Cancer Res"},{"key":"4479_CR4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1124\/pr.111.005538","volume":"64","author":"V Koppaka","year":"2012","unstructured":"Koppaka V, Thompson DC, Chen Y, Ellermann M, Nicolaou KC, Juvonen RO, Petersen D, Deitrich RA, Hurley TD, Vasiliou V: Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacol Rev. 2012, 64: 520-539. 10.1124\/pr.111.005538.","journal-title":"Pharmacol Rev"},{"key":"4479_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/path.2772","volume":"222","author":"MR Alison","year":"2010","unstructured":"Alison MR, Guppy NJ, Lim SML, Nicholson LJ: Finding cancer stem cells: are aldehyde dehydrogenases fit for purpose?. J Pathol. 2010, 222: 335-344. 10.1002\/path.2772.","journal-title":"J Pathol"},{"key":"4479_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.cbi.2011.10.007","volume":"195","author":"JS Moreb","year":"2012","unstructured":"Moreb JS, Ucar D, Han S, Amory JK, Goldstein AS, Ostmark B, Chang L-J: The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance. Chem Biol Interact. 2012, 195: 52-60. 10.1016\/j.cbi.2011.10.007.","journal-title":"Chem Biol Interact"},{"key":"4479_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.freeradbiomed.2011.11.033","volume":"52","author":"G Muzio","year":"2012","unstructured":"Muzio G, Maggiora M, Paiuzzi E, Oraldi M, Canuto RA: Aldehyde dehydrogenases and cell proliferation. Free Radic Biol Med. 2012, 52: 735-746. 10.1016\/j.freeradbiomed.2011.11.033.","journal-title":"Free Radic Biol Med"},{"key":"4479_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1158\/1541-7786.MCR-08-0393","volume":"7","author":"F Jiang","year":"2009","unstructured":"Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, Wang H, Liu Z, Su Y, Stass SA, Katz RL: Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res. 2009, 7: 330-338. 10.1158\/1541-7786.MCR-08-0393.","journal-title":"Mol Cancer Res"},{"key":"4479_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1476-4598-7-87","volume":"7","author":"JS Moreb","year":"2008","unstructured":"Moreb JS, Baker HV, Chang L-J, Amaya M, Lopez MC, Ostmark B, Chou W: ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells. Mol Cancer. 2008, 7: 87-10.1186\/1476-4598-7-87.","journal-title":"Mol Cancer"},{"key":"4479_CR10","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/j.1742-4658.2011.08071.x","volume":"278","author":"S Misra","year":"2011","unstructured":"Misra S, Heldin P, Hascall VC, Karamanos NK, Skandalis SS, Markwald RR, Ghatak S: Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J. 2011, 278: 1429-1443. 10.1111\/j.1742-4658.2011.08071.x.","journal-title":"FEBS J"},{"key":"4479_CR11","doi-asserted-by":"publisher","first-page":"7462","DOI":"10.1158\/1078-0432.CCR-09-0479","volume":"15","author":"BP Toole","year":"2009","unstructured":"Toole BP: Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities. Clin Cancer Res. 2009, 15: 7462-7468. 10.1158\/1078-0432.CCR-09-0479.","journal-title":"Clin Cancer Res"},{"key":"4479_CR12","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.ajpath.2011.11.015","volume":"180","author":"Y-C Wang","year":"2012","unstructured":"Wang Y-C, Yo Y-T, Lee H-Y, Liao Y-P, Chao T-K, Su P-H, Lai H-C: ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome. Am J Pathol. 2012, 180: 1159-1169. 10.1016\/j.ajpath.2011.11.015.","journal-title":"Am J Pathol"},{"key":"4479_CR13","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1158\/1535-7163.MCT-10-0504","volume":"9","author":"Y-W Chen","year":"2010","unstructured":"Chen Y-W, Chen K-H, Huang P-I, Chen Y-C, Chiou G-Y, Lo W-L, Tseng L-M, Hsu H-S, Chang K-W, Chiou S-H: Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma\u2013derived CD44(+)ALDH1(+) cells. Mol Cancer Ther. 2010, 9: 2879-2892. 10.1158\/1535-7163.MCT-10-0504.","journal-title":"Mol Cancer Ther"},{"key":"4479_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10549-011-1692-y","volume":"133","author":"AK Croker","year":"2012","unstructured":"Croker AK, Allan AL: Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells. Breast Cancer Res Treat. 2012, 133: 75-87. 10.1007\/s10549-011-1692-y.","journal-title":"Breast Cancer Res Treat"},{"key":"4479_CR15","doi-asserted-by":"publisher","first-page":"e14062","DOI":"10.1371\/journal.pone.0014062","volume":"5","author":"EL-H Leung","year":"2010","unstructured":"Leung EL-H, Fiscus RR, Tung JW, Tin VP-C, Cheng LC, Sihoe AD-L, Fink LM, Ma Y, Wong MP: Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS One. 2010, 5: e14062-10.1371\/journal.pone.0014062.","journal-title":"PLoS One"},{"key":"4479_CR16","doi-asserted-by":"publisher","first-page":"5506","DOI":"10.1158\/0008-5472.CAN-05-0626","volume":"65","author":"D Ponti","year":"2005","unstructured":"Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem\/progenitor cell properties. Cancer Res. 2005, 65: 5506-5511. 10.1158\/0008-5472.CAN-05-0626.","journal-title":"Cancer Res"},{"key":"4479_CR17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3892\/ijo.2013.1927","volume":"43","author":"M Salerno","year":"2013","unstructured":"Salerno M, Avnet S, Bonuccelli G, Eramo A, De Maria R, Gambarotti M, Gamberi G, Baldini N: Sphere-forming cell subsets with cancer stem cell properties in human musculoskeletal sarcomas. Int J Oncol. 2013, 43: 95-102.","journal-title":"Int J Oncol"},{"key":"4479_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/978-1-62703-287-2_15","volume":"980","author":"YJ Wang","year":"2013","unstructured":"Wang YJ, Bailey JM, Rovira M, Leach SD: Sphere-forming assays for assessment of benign and malignant pancreatic stem cells. Methods Mol Biol. 2013, 980: 281-290. 10.1007\/978-1-62703-287-2_15.","journal-title":"Methods Mol Biol"},{"key":"4479_CR19","doi-asserted-by":"publisher","first-page":"e3077","DOI":"10.1371\/journal.pone.0003077","volume":"3","author":"V Levina","year":"2008","unstructured":"Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE: Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One. 2008, 3: e3077-10.1371\/journal.pone.0003077.","journal-title":"PLoS One"},{"key":"4479_CR20","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.canlet.2012.08.021","volume":"328","author":"C-P Huang","year":"2013","unstructured":"Huang C-P, Tsai M-F, Chang T-H, Tang W-C, Chen S-Y, Lai H-H, Lin T-Y, Yang JC-H, Yang P-C, Shih J-Y, Lin S-B: ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors. Cancer Lett. 2013, 328: 144-151. 10.1016\/j.canlet.2012.08.021.","journal-title":"Cancer Lett"},{"key":"4479_CR21","doi-asserted-by":"publisher","first-page":"e13943","DOI":"10.1371\/journal.pone.0013943","volume":"5","author":"O Awad","year":"2010","unstructured":"Awad O, Yustein JT, Shah P, Gul N, Katuri V, O\u2019Neill A, Kong Y, Brown ML, Toretsky JA, Loeb DM: High ALDH activity identifies chemotherapy-resistant Ewing\u2019s sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition. PLoS One. 2010, 5: e13943-10.1371\/journal.pone.0013943.","journal-title":"PLoS One"},{"key":"4479_CR22","doi-asserted-by":"publisher","first-page":"e10731","DOI":"10.1371\/journal.pone.0010731","volume":"5","author":"L Prasmickaite","year":"2010","unstructured":"Prasmickaite L, Engesaeter B\u00d8, Skrbo N, Hellenes T, Kristian A, Oliver NK, Suo Z, Maelandsmo GM: Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma. PLoS One. 2010, 5: e10731-10.1371\/journal.pone.0010731.","journal-title":"PLoS One"},{"key":"4479_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1349-7006.2006.00184.x","volume":"97","author":"N Usami","year":"2006","unstructured":"Usami N, Fukui T, Kondo M, Taniguchi T, Yokoyama T, Mori S, Yokoi K, Horio Y, Shimokata K, Sekido Y, Hida T: Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients. Cancer Sci. 2006, 97: 387-394. 10.1111\/j.1349-7006.2006.00184.x.","journal-title":"Cancer Sci"},{"key":"4479_CR24","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.4161\/cc.10.9.15486","volume":"10","author":"P Marcato","year":"2011","unstructured":"Marcato P, Dean CA, Giacomantonio CA, Lee PWK: Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle. 2011, 10: 1378-1384. 10.4161\/cc.10.9.15486.","journal-title":"Cell Cycle"},{"key":"4479_CR25","doi-asserted-by":"publisher","first-page":"9937","DOI":"10.1158\/0008-5472.CAN-10-0881","volume":"70","author":"JP Sullivan","year":"2010","unstructured":"Sullivan JP, Spinola M, Dodge M, Raso MG, Behrens C, Gao B, Schuster K, Shao C, Larsen JE, Sullivan LA, Honorio S, Xie Y, Scaglioni PP, DiMaio JM, Gazdar AF, Shay JW, Wistuba II, Minna JD: Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res. 2010, 70: 9937-9948. 10.1158\/0008-5472.CAN-10-0881.","journal-title":"Cancer Res"},{"key":"4479_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007, 1: 555-567. 10.1016\/j.stem.2007.08.014.","journal-title":"Cell Stem Cell"},{"key":"4479_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10555-010-9216-5","volume":"29","author":"JP Sullivan","year":"2010","unstructured":"Sullivan JP, Minna JD, Shay JW: Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy. Cancer Metastasis Rev. 2010, 29: 61-72. 10.1007\/s10555-010-9216-5.","journal-title":"Cancer Metastasis Rev"},{"key":"4479_CR28","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s12032-011-9933-9","volume":"29","author":"D Liang","year":"2012","unstructured":"Liang D, Shi Y: Aldehyde dehydrogenase-1 is a specific marker for stem cells in human lung adenocarcinoma. Med Oncol. 2012, 29: 633-639. 10.1007\/s12032-011-9933-9.","journal-title":"Med Oncol"},{"key":"4479_CR29","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1038\/onc.2011.485","volume":"31","author":"C Canino","year":"2012","unstructured":"Canino C, Mori F, Cambria A, Diamantini A, Germoni S, Alessandrini G, Borsellino G, Galati R, Battistini L, Blandino R, Facciolo F, Citro G, Strano S, Muti P, Blandino G, Cioce M: SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells. Oncogene. 2012, 31: 3148-3163. 10.1038\/onc.2011.485.","journal-title":"Oncogene"},{"key":"4479_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ccr.2012.03.003","volume":"21","author":"JA Magee","year":"2012","unstructured":"Magee JA, Piskounova E, Morrison SJ: Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell. 2012, 21: 283-296. 10.1016\/j.ccr.2012.03.003.","journal-title":"Cancer Cell"},{"key":"4479_CR31","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrc2499","volume":"8","author":"JE Visvader","year":"2008","unstructured":"Visvader JE, Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008, 8: 755-768. 10.1038\/nrc2499.","journal-title":"Nat Rev Cancer"},{"key":"4479_CR32","first-page":"392647","volume":"2012","author":"MH Cruz","year":"2012","unstructured":"Cruz MH, Sid\u00e9n A, Calaf GM, Delwar ZM, Yakisich JS: The stemness phenotype model. ISRN Oncol. 2012, 2012: 392647-","journal-title":"ISRN Oncol"},{"key":"4479_CR33","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/sj.onc.1209327","volume":"25","author":"L Patrawala","year":"2006","unstructured":"Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG: Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene. 2006, 25: 1696-1708. 10.1038\/sj.onc.1209327.","journal-title":"Oncogene"},{"issue":"Suppl 1","key":"4479_CR34","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1007\/s12032-010-9721-y","volume":"28","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Piao B, Zhang Y, Hua B, Hou W, Xu W, Qi X, Zhu X, Pei Y, Lin H: Oxymatrine diminishes the side population and inhibits the expression of \u03b2-catenin in MCF-7 breast cancer cells. Med Oncol. 2011, 28 (Suppl 1): S99-S107.","journal-title":"Med Oncol"},{"key":"4479_CR35","doi-asserted-by":"publisher","first-page":"e2428","DOI":"10.1371\/journal.pone.0002428","volume":"3","author":"SJ Dylla","year":"2008","unstructured":"Dylla SJ, Beviglia L, Park I-K, Chartier C, Raval J, Ngan L, Pickell K, Aguilar J, Lazetic S, Smith-Berdan S, Clarke MF, Hoey T, Lewicki J, Gurney AL: Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS One. 2008, 3: e2428-10.1371\/journal.pone.0002428.","journal-title":"PLoS One"},{"key":"4479_CR36","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.18632\/oncotarget.1246","volume":"4","author":"J Liu","year":"2013","unstructured":"Liu J, Xiao Z, Wong SK-M, Tin VP-C, Ho K-Y, Wang J, Sham M-H, Wong MP: Lung cancer tumorigenicity and drug resistance are maintained through ALDHhiCD44hi tumor initiating cells. Oncotarget. 2013, 4: 1698-1711.","journal-title":"Oncotarget"},{"key":"4479_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4137\/CGM.S11333","volume":"6","author":"CM Telleria","year":"2013","unstructured":"Telleria CM: Repopulation of ovarian cancer cells after chemotherapy. Cancer Growth Metastasis. 2013, 6: 15-21.","journal-title":"Cancer Growth Metastasis"},{"key":"4479_CR38","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.bbrc.2007.01.159","volume":"355","author":"J Neuzil","year":"2007","unstructured":"Neuzil J, Stantic M, Zobalova R, Chladova J, Wang X, Prochazka L, Dong L, Andera L, Ralph SJ: Tumour-initiating cells vs. cancer \u201cstem\u201d cells and CD133: what\u2019s in the name?. Biochem Biophys Res Commun. 2007, 355: 855-859. 10.1016\/j.bbrc.2007.01.159.","journal-title":"Biochem Biophys Res Commun"},{"key":"4479_CR39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/stem.563","volume":"29","author":"P Marcato","year":"2011","unstructured":"Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, Joshi M, Helyer L, Pan L, Leidal A, Gujar S, Giacomantonio CA, Lee PWK: Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells. 2011, 29: 32-45. 10.1002\/stem.563.","journal-title":"Stem Cells"},{"key":"4479_CR40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12015-010-9208-4","volume":"7","author":"I Ma","year":"2011","unstructured":"Ma I, Allan AL: The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev. 2011, 7: 292-306. 10.1007\/s12015-010-9208-4.","journal-title":"Stem Cell Rev"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-14-304\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-14-304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:34:57Z","timestamp":1630553697000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-14-304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,30]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["4479"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-14-304","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,30]]},"assertion":[{"value":"26 November 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"304"}}